Vieroots, the health solutions company founded by Bollywood actor Suniel Shetty, is looking to fund up to $10 million in a Series A investment to expand its core operations.
Vieroots, a Bengaluru-based health tech firm founded in 2019, attracted Suniel Shetty as an early-stage investor in 2020.
EPLIMO is a cutting-edge technology used by the corporation, which specialises in personal consumer genomics and epigenetic management.
“Vieroots is perhaps the first personalised epigenetic lifestyle modification company, probably in the world. What we are doing is converging the genomic data and metabolic data to develop the Epigenetic Lifestyle Modifications recommendations best suited to people. This is done with the help of high-end Artificial Intelligence, and this is the highest level of personalized health available right now,” the company chairman Sajeev Nair said.
“The fund will be used to expand the user base as well as launch experience centres in the metro cities. We also plan global expansion in the meanwhile,” he said.
In the second year of operations itself the company has broken even with a revenue of about Rs.15 crore “We aim to at least double if not triple this in the next 18-24 months,” Nair said.
